Form EFFECT ZyVersa Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 16, 2024 |
| Accession Number: | 0001493152-24-027033 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- In HelloNation, Insurance Expert Scott Hopson Shares Auto Insurance Advice for Tourist Season
- NUU Introduces the All-New X10 5G: Fully Unlocked. Nationwide 5G. Exceptional Value.
- Fall 2026 Enrollment Opens at TRIMONT's Two Bay Area Campuses
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
